Stay updated on the progress of our pioneering endeavors.

5 traditional Chinese medicines, including liushen capsules and pills, have demonstrated the ability to suppress the novel coronavirus in in vitro experiments.

In the face of the “war” against the epidemic, we have remained steadfastly at their posts, endured trials and tribulations and thrown themselves into the front line.

Grand Pharma (China) Co., Ltd. and Griffith University have jointly announced the official conclusion of a strategic cooperation agreement.

The "2019 Annual Summit of China Chemical Pharmaceutical Industry" jointly organized and recommended by China Chemical Pharmaceutical Industry Association, China Pharmaceutical Business Association, China Non-Prescription Drug Association, China Pharmaceu

Recently, a drug-coated balloon for coronary intervention named "RESTORE paclitaxel-releasing coronary balloon dilatation catheter" (trade name: RESTORE DEB) has officially obtained the medical device registration certificate issued by the National Medica

On August 25, 2019, the 2019 (36th) National Medicinal Industry Information Annual Conference, China Grand Enterprises ranked the 13th in the list again with its strength。